Complex regimens are developed through extensive research and clinical trials that evaluate the efficacy and safety of various combinations and sequences of treatments. Oncologists consider factors such as the tumor's genetic profile, the patient's response to previous treatments, and potential side effects. Personalized medicine approaches, including the use of biomarkers and genomic sequencing, play a crucial role in designing these regimens.
